Le Lézard
Classified in: Health
Subject: MISCELLANEOUS

Nova Leap Health Corp. to Present at the ii6 Summit in Toronto


NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

HALIFAX, Dec. 10, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or "the Company"), a 2019 TSX Venture 50tm ranked company focused on the home health care industry, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the ii6 Summit to be held December 11, 2019 at the Omni King Edward Hotel in Toronto.  The event, which is sponsored by InvestorIntel Corp. and 724 Capital Corp., gives CEOs an opportunity to present their companies to multiple accredited investors. 

During the Main Event, Mr. Dobbin plans to discuss the following:

Record Quarterly Results ? Q3

The quarter ending September 30, 2019 results were released on November 7, 2019 and highlighted:

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/81334ef1-fb3f-4764-ad37-c806a2b2f2b5 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0b74449b-5400-47f2-af54-c30699f48056

Industry and Strategy

About Nova Leap

Nova Leap is an acquisitive home health care services company operating in one of the fastest growing industries in the U.S. & Canada.  The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care.  Nova Leap achieved the #10 Ranking in the 2019 TSX Venture 50tm in the Clean Technology & Life Sciences sector.  The Company is geographically diversified with operations in 5 different U.S. states: Vermont, New Hampshire, Massachusetts, Rhode Island and Oklahoma as well as Nova Scotia, Canada.

NON-GAAP MEASURES:

Gross margin is service revenue less cost of services;

Earnings before interest, taxes, depreciation and amortization ("EBITDA"), is calculated as the net loss, before acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation and stock-based compensation), interest expense, net of interest income and income tax expense.

FORWARD LOOKING INFORMATION:

Certain information in this press release may contain forward-looking statements, such as statements regarding future expansions and cost savings, the Company's expected annualized recurring revenue run rate and plans regarding future acquisitions and financings. This information is based on current expectations and assumptions, including assumptions concerning the Company's ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include regulatory changes affecting the home care industry, unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at www.sedar.com.

For further information:

Christopher Dobbin, CPA, CA, Director, President and CEO Nova Leap Health Corp., T: 902 401 9480   F:  902 482 5177 cdobbin@novaleaphealth.com

CAUTIONARY STATEMENT:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 


These press releases may also interest you

at 23:22
Hawkeye Systems, Inc. is pleased to announce the creation of a strong body cam platform for biosurveillance and real-time monitoring of issues such as the Coronavirus "It's the personnel at the front line that are likely to be exposed first so our...

at 22:00
Capsule Technologies, a leading global provider of medical device integration, clinical surveillance, and patient monitoring for hospitals and healthcare organizations, announced today it opened a new office in Dubai's Jebel Ali Free Zone expanding...

at 22:00
In an effort to focus on continuous patient safety and quality improvements, as well as address dynamic changes in today's global health care environment, Joint Commission International (JCI) announces the publication of The Joint Commission...

at 21:55
A December 16 article on Healthline tackles the question of whether it is better to brush or floss first when practicing dental hygiene. The article states that, by flossing first, individuals are dislodging particles stuck between teeth that are...

at 21:45
Blue Health Intelligence (BHI) published an article confirming Airrosti's methods improve care efficiency, reduce total cost of care, and limit the utilization of high-cost imaging and surgeries for musculoskeletal (MSK) injuries. Airrosti, a large...

at 21:19
The coronavirus outbreak is having a potentially significant social and economic impact in China. WuXi Biologics is closely monitoring the coronavirus outbreak and is complying with guidance from the relevant authorities. Our management team is...



News published on 10 december 2019 at 16:15 and distributed by: